Medistep Healthcare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	496.55	390.72	276.47	76.24
Revenue Growth (YoY)	27.09%	41.33%	262.61%	-
Cost of Revenue	435.59	341.93	261.26	70.53
Gross Profit	60.96	48.79	15.21	5.71
Selling, General & Admin	3.06	1.99	1.42	1.4
Other Operating Expenses	1.89	1.28	0.4	0.73
Operating Expenses	5.27	3.49	2.48	2.75
Operating Income	55.69	45.3	12.74	2.96
Interest Expense	-0.29	-0.84	-1.33	-0.43
Other Non Operating Income (Expenses)	-0.01	0	0	-
EBT Excluding Unusual Items	55.39	44.47	11.41	2.54
Gain (Loss) on Sale of Assets	-	-	0.9	-
Pretax Income	55.39	44.47	12.31	2.54
Income Tax Expense	13.95	11.19	3.1	0.64
Net Income	41.44	33.28	9.21	1.9
Preferred Dividends & Other Adjustments	-	4.14	-	-
Net Income to Common	41.44	29.14	9.21	1.9
Net Income Growth	24.54%	261.29%	385.50%	-
Shares Outstanding (Basic)	10	1	-	-
Shares Outstanding (Diluted)	10	1	-	-
Shares Change (YoY)	608.37%	-	-	-
EPS (Basic)	4.01	19.96	-	-
EPS (Diluted)	4.01	19.96	-	-
EPS Growth	-79.92%	-	-	-
Free Cash Flow	0.22	-71.15	4.42	-
Free Cash Flow Per Share	0.02	-48.76	-	-
Gross Margin	12.28%	12.49%	5.50%	7.49%
Operating Margin	11.21%	11.59%	4.61%	3.88%
Profit Margin	8.35%	7.46%	3.33%	2.49%
Free Cash Flow Margin	0.04%	-18.21%	1.60%	-
EBITDA	56.01	45.52	13.39	3.58
EBITDA Margin	11.28%	11.65%	4.84%	4.69%
D&A For EBITDA	0.32	0.22	0.65	0.62
EBIT	55.69	45.3	12.74	2.96
EBIT Margin	11.21%	11.59%	4.61%	3.88%
Effective Tax Rate	25.18%	25.17%	25.16%	25.17%
Revenue as Reported	496.59	390.82	277.37	76.24
Advertising Expenses	0	0.01	0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.